Premenstrual Syndrome Treatments

Find Premenstrual Syndrome Treatments

Generic Name

Paroxetine

Brand Names

Brisdelle, Paxil

FDA approval date: July 30, 2003

Classification: Serotonin Reuptake Inhibitor

Form: Tablet, Suspension, Capsule

What is Brisdelle (Paroxetine)?

BRISDELLE is indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause. Limitations of Use: BRISDELLE is not indicated for the treatment of any psychiatric condition. BRISDELLE has a lower recommended paroxetine dosage than that used to treat major depressive disorder, obsessive compulsive disorder, panic disorder, generalized anxiety disorder, social anxiety disorder, and post-traumatic stress disorder. The safety and effectiveness of the lower BRISDELLE dosage has not been established for any psychiatric condition. Patients who require paroxetine for treatment of a psychiatric condition should discontinue BRISDELLE and initiate a paroxetine-containing product that is indicated for such use. BRISDELLE is a selective serotonin reuptake inhibitor indicated for the treatment of moderate to severe vasomotor symptoms associated with menopause Limitations of Use : BRISDELLE is not indicated for the treatment of any psychiatric condition

Approved To Treat

Top Global Experts

View All

Save this treatment for later

Not sure about your diagnosis?

Check Your Symptoms

Tired of the same old research?

Check Latest Advances

Related Clinical Trials

A Phase I/II, Open-label, Adaptive Two-part Trial to Evaluate the Safety, Efficacy, Optimal Dose and Pharmacokinetics of BNT326 as Monotherapy and in Combination With Cancer Immunotherapies in Participants With Advanced Solid Tumors

Enrollment Status: Recruiting

Publish Date: May 22, 2026

Intervention Type: Drug

Study Phase: Phase 1/Phase 2

Summary: This study will evaluate the safety, efficacy, optimal dose, and pharmacokinetics (PK) of BNT326 as monotherapy (Part 1) and as combination treatment with immunotherapeutic agents (Part 2) in participants with histologically or cytologically confirmed solid tumors that are advanced (i.e., either metastatic or recurrent tumors with no further definitive treatment possible) and/or have relapsed/prog...

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Enrollment Status: Recruiting

Publish Date: April 24, 2026

Intervention Type: Drug

Summary: Over half of women in the US who are breastfeeding their infants take prescription drugs. You are being asked to participate in this study because you are breastfeeding your infant and are currently taking, as part of your medical care, at least one of the drugs we are studying. We are interested in studying drugs commonly prescribed to women who are breastfeeding so we can learn more about the am...

Fostering Ukraine's Capacity in the Delivery and Research of Innovative Evidence-based PTSD Treatment

Enrollment Status: Recruiting

Publish Date: January 15, 2026

Intervention Type: Behavioral, Drug

Study Phase: Not Applicable

Summary: The Lux4UA project aims to support mental health treatment in Ukraine, especially for those who have experienced traumatic events due to the ongoing conflict and forced displacement. As rates of Post-Traumatic Stress Disorder (PTSD) rise among civilians, military personnel, and refugees, the need for effective trauma care becomes urgent. PTSD is a mental health condition that can develop after exp...

View All Clinical Trials